(VRTX) Vertex Pharmaceuticals - Performance 21.6% in 12m
Compare VRTX with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
57.16%
#8 in Group
Rel. Strength
79.14%
#1670 in Universe
Total Return 12m
21.61%
#37 in Group
Total Return 5y
83.39%
#22 in Group
P/E -
(?) Percentile in Group
P/E Forward 27.8
73th Percentile in Group
PEG 1.34
83th Percentile in Group
FCF Yield -0.65%
77th Percentile in Group
12m Total Return: VRTX (21.6%) vs XBI (-6.5%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-8.25% | 25.2% | 163% | 11.9 | 10.6 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
0.89% | 22.3% | 40.6% | 24.7 | 20.3 | 1.8 | 27.1% | - |
AMGN NASDAQ Amgen |
-11.6% | 4.69% | 33.7% | 36.6 | 13.3 | 0.94 | -18.8% | -20% |
LONN SW Lonza |
-1.09% | 7.58% | 35.2% | 60.7 | 31.7 | 1.15 | 12.6% | -10.3% |
BIM PA Biomerieux |
-2.83% | 12.9% | -1.51% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-7.32% | 33% | -9.75% | 24.3 | 22.8 | 0.91 | 47.7% | 3.93% |
ERF PA Eurofins Scientific SE |
9.29% | -9.24% | 24.2% | 24.3 | 11.7 | 0.58 | -70.8% | -17.1% |
GRFS NASDAQ Grifols |
-7.23% | 11% | -64% | 26.9 | 11 | 0.23 | -45.4% | -33.9% |
Performance Comparison: VRTX vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for VRTX
Total Return (including Dividends) | VRTX | XBI | S&P 500 |
---|---|---|---|
1 Month | -3.78% | -10.94% | -6.73% |
3 Months | 11.98% | -14.92% | -11.93% |
12 Months | 21.61% | -6.46% | 7.24% |
5 Years | 83.39% | -19.21% | 100.61% |
Trend Score (consistency of price movement) | VRTX | XBI | S&P 500 |
1 Month | -17.8% | -52.8% | -63.5% |
3 Months | 59.9% | -92.8% | -90.3% |
12 Months | 22.3% | -32.4% | 60.6% |
5 Years | 87.4% | -53.3% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #69 | 8.05% | 3.17% |
3 Month | #19 | 31.6% | 27.2% |
12 Month | #38 | 30.0% | 13.4% |
5 Years | #22 | 127% | -8.58% |
FAQs
Does VRTX Vertex Pharmaceuticals outperforms the market?
Yes,
over the last 12 months VRTX made 21.61%, while its related Sector, the SPDR S&P Biotech (XBI) made -6.46%.
Over the last 3 months VRTX made 11.98%, while XBI made -14.92%.
Over the last 3 months VRTX made 11.98%, while XBI made -14.92%.
Performance Comparison VRTX vs Indeces and Sectors
VRTX vs. Indices VRTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -0.52% | 2.95% | 11.5% | 14.4% |
US NASDAQ 100 | QQQ | -1.00% | 3.58% | 11.4% | 14.0% |
US Dow Jones Industrial 30 | DIA | 1.51% | 3.13% | 10.9% | 17.1% |
German DAX 40 | DAX | -1.74% | 0.16% | -8.37% | 1.28% |
Shanghai Shenzhen CSI 300 | CSI 300 | 0.05% | -0.39% | 10.4% | 12.4% |
Hongkong Hang Seng | HSI | -3.19% | -0.06% | 6.99% | 4.83% |
India NIFTY 50 | INDA | -2.67% | -5.81% | 8.18% | 18.6% |
Brasil Bovespa | EWZ | -4.79% | -4.24% | 6.48% | 30.4% |
VRTX vs. Sectors VRTX is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -1.23% | 3.07% | 2.40% | 6.54% |
Consumer Discretionary | XLY | -1.96% | 3.06% | 6.23% | 10.3% |
Consumer Staples | XLP | -0.67% | -6.76% | 3.57% | 10.3% |
Energy | XLE | -0.59% | 8.72% | 12.8% | 34.3% |
Financial | XLF | -1.22% | 1.07% | 2.66% | 3.78% |
Health Care | XLV | 1.75% | 3.98% | 13.8% | 24.0% |
Industrial | XLI | 0.08% | 2.25% | 11.7% | 17.6% |
Materials | XLB | -0.26% | 2.07% | 18.8% | 27.5% |
Real Estate | XLRE | -0.29% | -0.55% | 11.9% | 6.88% |
Technology | XLK | -0.79% | 5.22% | 17.8% | 20.5% |
Utilities | XLU | -0.41% | -3.98% | 7.90% | -0.07% |
Aerospace & Defense | XAR | 0.93% | -0.60% | 2.16% | -0.26% |
Biotech | XBI | -3.94% | 7.16% | 22.9% | 28.1% |
Homebuilder | XHB | -2.05% | 4.34% | 26.3% | 32.1% |
Retail | XRT | -2.39% | 1.61% | 15.0% | 27.9% |